We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.7B
AUM Growth
+$329M
Cap. Flow
-$710M
Cap. Flow %
-4.25%
Top 10 Hldgs %
19.03%
Holding
2,687
New
132
Increased
900
Reduced
1,002
Closed
108

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$232M
2
BNL icon
Broadstone Net Lease
BNL
+$66.5M
3
APH icon
Amphenol
APH
+$64M
4
SNPS icon
Synopsys
SNPS
+$46.8M
5
XLNX
Xilinx Inc
XLNX
+$46.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$78M
2
KEYS icon
Keysight
KEYS
+$69.7M
3
ADP icon
Automatic Data Processing
ADP
+$68.4M
4
CSCO icon
Cisco
CSCO
+$60.5M
5
OMC icon
Omnicom Group
OMC
+$52.8M

Sector Composition

Rank Sector Weight
1 Technology 23.23%
2 Healthcare 13.49%
3 Financials 11.88%
4 Consumer Discretionary 9.14%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOPE icon
926
Grand Canyon Education
LOPE
$3.98B
$295K ﹤0.01%
3,696
+574
+18% +$52K
EEFT icon
927
Euronet Worldwide
EEFT
$2.92B
$294K ﹤0.01%
3,233
+974
+43% +$95K
VSS icon
928
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
$294K ﹤0.01%
2,799
-2,715
-49% -$283K
MASI
929
DELISTED
Masimo
MASI
$292K ﹤0.01%
1,237
+349
+39% +$78.2K
TDY icon
930
Teledyne Technologies
TDY
$30.1B
$291K ﹤0.01%
941
+612
+186% +$193K
MTEM
931
DELISTED
Molecular Templates, Inc.
MTEM
$291K ﹤0.01%
1,778
-1,066
-37% -$190K
VIVO
932
DELISTED
Meridian Bioscience Inc
VIVO
$291K ﹤0.01%
17,153
+11,434
+200% +$222K
NVAX icon
933
Novavax
NVAX
$1.22B
$290K ﹤0.01%
2,678
+388
+17% +$47.3K
DVYE icon
934
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$289K ﹤0.01%
9,600
KRTX
935
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$287K ﹤0.01%
3,720
+935
+34% +$79.7K
CMA
936
DELISTED
Comerica
CMA
$283K ﹤0.01%
7,406
-5,395
-42% -$207K
KDP icon
937
Keurig Dr Pepper
KDP
$43B
$282K ﹤0.01%
10,270
-1,458
-12% -$42.7K
OFLX icon
938
Omega Flex
OFLX
$292M
$280K ﹤0.01%
1,790
+265
+17% +$33.2K
KKR icon
939
KKR & Co
KKR
$90.7B
$279K ﹤0.01%
8,142
KWR icon
940
Quaker Houghton
KWR
$2.69B
$279K ﹤0.01%
1,553
+2
+0.1% +$384
TIF
941
DELISTED
Tiffany & Co.
TIF
$279K ﹤0.01%
2,417
+240
+11% +$29.2K
VRSN icon
942
VeriSign
VRSN
$25.9B
$278K ﹤0.01%
1,360
+1
+0.1% +$207
JJSF icon
943
J&J Snack Foods
JJSF
$1.44B
$277K ﹤0.01%
2,128
+144
+7% +$18.7K
TM icon
944
Toyota
TM
$227B
$276K ﹤0.01%
2,088
-2,334
-53% -$304K
KYNB
945
Kyntra Bio
KYNB
$27.5M
$275K ﹤0.01%
268
+67
+33% +$72.1K
WIX icon
946
WIX.com
WIX
$2.37B
$275K ﹤0.01%
1,081
-2
-0.2% -$551
PFS icon
947
Provident Financial Services
PFS
$3.24B
$273K ﹤0.01%
22,445
+301
+1% +$4.05K
WTW icon
948
Willis Towers Watson
WTW
$31.7B
$273K ﹤0.01%
1,315
+59
+5% +$12K
FNV icon
949
Franco-Nevada
FNV
$42.7B
$272K ﹤0.01%
1,950
+1,332
+216% +$198K
VMW
950
DELISTED
VMware, Inc
VMW
$266K ﹤0.01%
1,860
+189
+11% +$26.8K

Similar funds

Glenmede Trust's Q3 2020 Portfolio in Review

As of Q3 2020, Glenmede Trust held 2,687 positions worth $16.7B, up 2% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glenmede Trust withdrew a net $710M in Q3 2020, closing 108 positions and reducing 1,002 holdings. Its most notable exit was IBERIABANK Corp, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Broadstone Net Lease worth $67.3M.

  • Glenmede Trust's largest Q3 2020 buy was Broadstone Net Lease: 4,009,897 shares worth $67.3M.
  • Glenmede Trust added most to Progressive in Q3 2020, an estimated $232M increase.
  • Glenmede Trust's biggest Q3 2020 reduction was Apple, cutting an estimated $78M.
  • Glenmede Trust fully exited IBERIABANK Corp in Q3 2020, selling an estimated $18.1M.
  • Glenmede Trust's ten largest holdings make up 19% of its $16.7B portfolio in Q3 2020.
  • Glenmede Trust opened 132 new positions and closed 108 in Q3 2020.
  • Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $16.7B.

Based on Glenmede Trust's 13F filing for Q3 2020, filed 16 Nov 2020.